Palpation fails to reduce breast cancer mortality

Article

Experience compiled from nearly half a million women suggests that breast self-examination has a negligible effect in reducing breast cancer-related deaths. The practice may even be putting an unnecessary strain on breast care resources, according to researchers in Denmark.

Experience compiled from nearly half a million women suggests that breast self-examination has a negligible effect in reducing breast cancer-related deaths. The practice may even be putting an unnecessary strain on breast care resources, according to researchers in Denmark.

Reputed medical institutions as well as patient advocacy groups recommend that women give themselves a breast self-exam every month, starting by age 20, to check for lumps or other suspicious changes. Though palpation is widely praised as a valuable aid to early detection, a recent review of two large studies from Russia and China found no evidence that it could reduce breast cancer fatalities and concluded that it should not replace established screening methods, according to principal investigator Jan Peter Kosters, Ph.D.

"At present, screening by breast self-examination or physical examination [by a trained health worker] cannot be recommended," Kosters said.

Kosters and colleagues at the Nordic Cochrane Centre in Copenhagen analyzed data from 388,535 women. The investigators found that the women in the cohort who did breast self-exams had almost twice as many false-positive biopsies compared with women who did not perform the exams. They published their findings in the latest issue of The Cochrane Library.

Women who performed the palpation test had 3406 biopsies, whereas those who did not had only 1856 biopsies. The difference in the breast cancer death rate between the two groups was not statistically significant. The Chinese study also compared breast cancer management strategies from the self-exam versus the no-exam groups and found that rates of mastectomy and breast-conserving surgery were similar.

Study findings do not mean that women should stop using the self-evaluation technique, and researchers realize that some women will want to continue performing breast palpation exams. Women should always seek medical advice, however, if they detect any change in their breasts, Kosters said.

"We suggest that the lack of supporting evidence should be discussed with these women to enable them to make an informed decision," he said.

For more information from the Diagnostic Imaging archives:

MR elastography shakes up assumptions about body MR

Ultrasound manufacturers address patient care with product innovations

Breast elastography techniques break new ground

Electronic detectors spring from an x-ray heritage

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.